Early innovations in opioid use disorder treatment and harm reduction during the COVID-19 pandemic: a scoping review
Abstract Background The COVID-19 pandemic has exerted a significant toll on the lives of people who use opioids (PWUOs). At the same time, more flexible regulations around provision of opioid use disorder (OUD) services have led to new opportunities for facilitating access to services for PWUOs. In...
Guardado en:
Autores principales: | Noa Krawczyk, Adetayo Fawole, Jenny Yang, Babak Tofighi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/859133be9a3d4fbfb0d6ac7727168bf6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Perspectives on extended-release naltrexone induction among patients living with HIV and opioid use disorder: a qualitative analysis
por: Kim A. Hoffman, et al.
Publicado: (2021) -
Opioid use disorder from poppy seed tea successfully treated with buprenorphine in primary care: a case report
por: Scott Hagan, et al.
Publicado: (2021) -
A systematic review of GWAS identified SNPs associated with outcomes of medications for opioid use disorder
por: Caroul Chawar, et al.
Publicado: (2021) -
Opioid Poisoning and Opioid Use Disorder in Older Trauma Patients
por: Daoust R, et al.
Publicado: (2020) -
Feasibility and acceptability of electronic administration of patient reported outcomes using mHealth platform in emergency department patients with non-medical opioid use
por: Kathryn Hawk, et al.
Publicado: (2021)